KLF4 also functions as an oncogene to promote proliferation of breast cancer and bladder cancer cells in the presence of RASV12-Cyclin-D1 signaling or the absence of p21CIP1 [24, 37]. Here, CDKN1A is linked to urinary bladder carcinoma.